-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential utility of biomarkers in the diagnosis and treatment of ALS
Benjamin Chee Chuan Cheah, Steve Vucic, Matthew Colm Kiernan
Review: Clinical Trail Outcomes: Clinical Investigation